Graham Griffiths - 31 Dec 2021 Form 5 Insider Report for Vaccitech plc (BRNS)

Role: Chief Business Officer
Signature: /s/ William Enright, Attorney-in-Fact
Issuer symbol: BRNS
Transactions as of: 31 Dec 2021
Net transactions value: +$46.32
Form type: 5
Filing time: 11 Feb 2022, 18:55:56 UTC
Next filing: 11 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VACC	Ordinary Shares	Options Exercise	$40.91	+102,279	+102279%	$0.000400^*	102,379	17 Dec 2021	Direct	F1
transaction	VACC	Ordinary Shares	Options Exercise	$2.32	+5,794	+5.7%	$0.000400^*	108,173	17 Dec 2021	Direct	F1
transaction	VACC	Ordinary Shares	Options Exercise	$1.85	+4,636	+4.3%	$0.000400^*	112,809	17 Dec 2021	Direct	F1
transaction	VACC	Ordinary Shares	Options Exercise	$1.24	+3,090	+2.7%	$0.000400^*	115,899	17 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VACC	Share Option (Right to Buy)	Options Exercise	$0	-102,279	-100%	$0.000000^*	0	17 Dec 2021	Ordinary Shares	$102,279	$0.000400	Direct	F1, F2
transaction	VACC	Share Option (Right to Buy)	Options Exercise	$0	-5,794	-75%	$0.000000	1,931	17 Dec 2021	Ordinary Shares	$5,794	$0.000400	Direct	F1, F3
transaction	VACC	Share Option (Right to Buy)	Options Exercise	$0	-4,636	-50%	$0.000000	4,634	17 Dec 2021	Ordinary Shares	$4,636	$0.000400	Direct	F1, F4
transaction	VACC	Share Option (Right to Buy)	Options Exercise	$0	-3,090	-25%	$0.000000	9,270	17 Dec 2021	Ordinary Shares	$3,090	$0.000400	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	This option shall vest and become exercisable in four equal annual installments, with the first installment vested on October 16, 2018. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
F3	This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2019. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
F4	This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2020. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
F5	This option shall vest and become exercisable in four equal annual installments, with the first installment vested on January 1, 2021. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020.